Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species

被引:69
|
作者
Gerassimou, C.
Kotanidou, A.
Zhou, Z.
Simoes, D. C. M.
Roussos, C.
Papapetropoulos, A. [1 ]
机构
[1] Univ Athens, Dept Crit Care & Pulm Serv, George P Livanos Lab, Evangelismos Hosp, Athens 10675, Greece
[2] Univ Patras, Dept Pharm, Mol Pharmacol Lab, Patras, Greece
关键词
cGMP; soluble guanylyl cyclase; reactive oxygen species; nitric oxide;
D O I
10.1038/sj.bjp.0707179
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Superoxide anions produced during vascular disease scavenge nitric oxide ( NO), thereby reducing its biological activity. The aim of the present study was to investigate whether reactive oxygen species ( ROS) have a direct effect on soluble guanylyl cyclase ( sGC) subunit levels and function and to ascertain the mechanism( s) involved. Experimental approach: Rat aortic smooth muscle cells ( RASM) or freshly isolated vessels were exposed to reactive oxygen species ( ROS)-generating agents and sGC subunit expression was determined at the mRNA and/or protein level. cGMP accumulation was also determined in RASM exposed to ROS. Key results: Incubation of smooth muscle cells with H2O2, xanthine/xanthine oxidase ( X/XO) or menadione sodium bisulphite ( MSB) significantly decreased protein levels of alpha 1 and beta 1 subunits of sGC and reduced SNP-induced cGMP formation. Similarly, sGC expression was reduced in freshly isolated vessels exposed to ROS-generating agents. The ROS-triggered inhibition of alpha 1 and beta 1 levels was not blocked by proteasome inhibitors, suggesting that decreased sGC protein was not due to protein degradation through this pathway. Real time RT-PCR analysis demonstrated a 68% reduction in steady state mRNA levels for the alpha 1 subunit following exposure to H2O2. In addition, alpha 1 promoter-driven luciferase activity in RASM decreased by 60% after H2O2 treatment. Conclusion and implications: We conclude that oxidative stress triggers a decrease in sGC expression and activity that results from reduced sGC steady state mRNA levels. Altered sGC expression is expected to contribute to the changes in vascular tone and remodeling observed in diseases associated with ROS overproduction.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 50 条
  • [41] Genomic structure and expression of the sea urchin soluble guanylyl cyclase β subunit gene
    Tanabe, Y
    Suzuki, N
    ZOOLOGICAL SCIENCE, 2001, 18 (06) : 811 - 817
  • [42] Soluble guanylyl cyclase activators increase the expression of tolerance to morphine analgesic effect
    Durmus, N.
    Bagcivan, I
    Ozdemir, E.
    Altun, A.
    Gursoy, S.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (06): : 334 - 339
  • [43] Toward structural insights into activation and modulation of the soluble guanylyl cyclase
    Kumar, Vijay
    Stamler, Jonathan
    Stasch, Johannes-Peter
    Hahn, Michael
    Schaefer, Martina
    Giannis, Athanassios
    Papapetropoulos, Andreas
    van den Akker, Focco
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2014, 42 : 112 - 112
  • [44] Presence of soluble and particulate guanylyl cyclase in the same hippocampal astrocytes
    Teunissen, C
    Steinbusch, H
    Markerink-van Ittersum, M
    Koesling, D
    de Vente, J
    BRAIN RESEARCH, 2001, 891 (1-2) : 206 - 212
  • [45] The deactivation of soluble guanylyl cyclase by redox-active agents
    Dierks, EA
    Burstyn, JN
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 351 (01) : 1 - 7
  • [46] EXPRESSION OF SOLUBLE GUANYLYL CYCLASE - CATALYTIC ACTIVITY REQUIRES 2 ENZYME SUBUNITS
    HARTENECK, C
    KOESLING, D
    SOLING, A
    SCHULTZ, G
    BOHME, E
    FEBS LETTERS, 1990, 272 (1-2): : 221 - 223
  • [47] Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation
    Sayed, Nazish
    Baskaran, Padmamalini
    Ma, Xiaolei
    van den Akker, Focco
    Beuve, Annie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (30) : 12312 - 12317
  • [48] Role of soluble guanylyl cyclase in renal afferent and efferent arterioles
    Wennysia, I. C.
    Zhao, L.
    Schomber, T.
    Braun, D.
    Golz, S.
    Summer, H.
    Benardeau, A.
    Lai, E. Y.
    Lichtenberger, F-B
    Schubert, R.
    Persson, P. B.
    Xu, M. Z.
    Patzak, A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (02) : F193 - F202
  • [49] Biased activity of soluble guanylyl cyclase: the Janus face of thymoquinone
    Detremmerie, Charlotte
    Vanhoutte, Paul M.
    Leungn, Susan
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (04) : 401 - 408
  • [50] The effect of hypercholesterolemia on platelet soluble guanylyl cyclase
    Kottenberg-Assenmacher, E
    Weber, M
    Kojda, G
    VASCULAR PHARMACOLOGY, 2003, 40 (03) : 141 - 147